Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Higgins, Stevan Jovanovich, and Charles Swindell

Premium

Caliper Life Sciences has named Thomas Higgins as its executive vice president and chief financial officer, the Hopkinton, Mass.-based company said last week. The appointment will become effective in early January 2005.

Higgins currently serves as executive vice president of operations and chief financial officer for VI Technologies. Prior to this, he held various positions at Cabot Corporation and PricewaterhouseCoopers. Higgins holds a BBA from Boston University.


Stevan Jovanovich, former vice president of global research at Amersham Biosciences, has been named president and CEO of Microchip Biotechnologies of Fremont, Calif., a startup that last month received a $6.1 million grant from the National Human Genome Research Institute to develop a DNA sequencing technology.


Charles Swindell joined Phyton Biotech of Ithaca, NY, as vice president of research and development, the plant cell culture technology company said last week. Swindell will manage the transition of Phyton, a subsidiary of DFB Pharmaceuticals, into a fully integrated biotechnology company. Swindell previously was chairman of the department of chemistry at Bryn Mawr College.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.